Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Gynecologic Oncology|September 29, 2020
Primary treatment and relative survival by stage and age in vulvar squamous cell carcinoma: A population-based SweGCG studyKristina Hellman, Erik Holmberg, Maria Bjurberg, et al.Acta Obstetricia Et Gynecologica Scandinavica|March 15, 2021
Preoperative and intraoperative assessment of myometrial invasion in endometrial cancer-A Swedish Gynecologic Cancer Group (SweGCG) studyBjörg Jónsdóttir, Janusz Marcickiewicz, Christer Borgfeldt, et al.BMC Cancer|June 3, 2021
Survival in endometrial cancer in relation to minimally invasive surgery or open surgery - a Swedish Gynecologic Cancer Group (SweGCG) studyChrister Borgfeldt, Erik Holmberg, Janusz Marcickiewicz, et al.Gynecologic Oncology|October 30, 2025
Primary treatment and survival in malignant ovarian germ cell tumors: A nationwide population-based Swedish Gynecologic Cancer Group (SweGCG) studyCamilla Sköld, Angelique Flöter Rådestad, Katja Stenström Bohlin, et al.Gynecologic Oncology|September 4, 2019
Primary treatment patterns and survival of cervical cancer in Sweden: A population-based Swedish Gynecologic Cancer Group StudyMaria Bjurberg, Erik Holmberg, Christer Borgfeldt, et al.Gynecologic Oncology|February 14, 2021
Implementation of National Guidelines increased survival in advanced ovarian cancer - A population-based nationwide SweGCG studyPernilla Dahm-Kähler, Erik Holmberg, Mikael Holtenman, et al.Acta Oncologica (Stockholm, Sweden)|August 3, 2019
Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) studyKarin Stålberg, Maria Bjurberg, Christer Borgfeldt, et al.Acta Obstetricia Et Gynecologica Scandinavica|May 7, 2025
Validation of data quality in the Swedish quality register of gynecologic cancer for cervical cancer and vulvar cancer-a Swedish gynecologic cancer group (Swe-GCG) studyMaria Bjurberg, Kristina Hellman, Tim A Säll, et al.Gynecologic Oncology|January 15, 2019
Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trialMichel Fabbro, Kathleen N Moore, Anne Dørum, et al.Pageof 4